BioSpace News Archive

Deals

Advanced Accelerator Applications Announces Commencement of Novartis Tender Offer

The Offer will expire at 12:00 midnight, New York City time, on January 19, 2018, unless extended (the latest time and date at which the Offer will expire, the “Expiration Date”).

December 7, 2017

·

9 min read

Business

Median Technologies Inks a Research Collaboration Agreement for Lung Cancer Screening Programs With Xingtai People’s Hospital, Xingtai City, China

Within the frame of the agreement, Median’s MediScan® image analysis technology will be used to conduct lung cancer screening programs organized under the aegis of Xingtai People’s Hospital in Xingtai City.

December 7, 2017

·

3 min read

Expert Review Panel for Diagnostics Approves Atomo HIV Self Test for Procurement by Unitaid and the Global Fund

Following on from its recent CE Mark approval, which enables Atomo to market the product in Europe, the ERP-D approval will facilitate further expansion and commercial roll-out of the product in LMICs.

December 7, 2017

·

2 min read

Drug Development

CEL-SCI Reports Recent Data Review By the Independent Data Monitoring Committee for Its Pivotal Phase III Head and Neck Cancer Study

CEL-SCI Corporation announced today that the Independent Data Monitoring Committee (IDMC) for the Company’s pivotal Phase 3 head and neck cancer study of its investigational immunotherapy Multikine* (Leukocyte Interleukin, Injection) has completed its review of the Phase 3 study data.

December 7, 2017

·

3 min read

Business

Cardax Hires Gilbert Shin as VP, Retail Sales and Marketing

Mr. Shin will lead the Company’s recently announced national rollout of ZanthoSyn to the more than 3,000 corporate stores across the U.S. owned and operated by GNC.

December 7, 2017

·

4 min read

Business

Cantel Medical Reports Record Financial Results for its First Quarter Fiscal Year 2018

Cantel Medical today announced financial results for its first quarter ended October 31, 2017.

December 7, 2017

·

21 min read

Business

Castle Biosciences Announces the Appointment of Frank Stokes as Chief Financial Officer

He joined Castle Biosciences effective December 4, 2017.

December 7, 2017

·

2 min read

Pharm Country

Pfizer Announces Private Exchange Offer for Its 6.500 Per Cent

Pfizer today announced that it has commenced a private offer to exchange (the “Exchange Offer”) any and all of its outstanding £1,500,000,000 6.500 per cent.

December 7, 2017

·

27 min read

Business

China Cord Blood Corporation Announces Results of 2017 Annual General Meeting

China Cord Blood Corporation today announced the results of its 2017 Annual General Meeting, which was held on December 7, 2017, in Hong Kong S.A.R., China.

December 7, 2017

·

2 min read

Drug Development

MeiraGTx Receives Rare Pediatric Disease Designation for A001 for the Treatment of Leber’s Congenital Amaurosis and Treats First Pediatric Patient in Phase I/II Clinical Trial

The primary endpoint of the study is to determine the safety of the treatment. Secondary endpoints include improvement in visual function including a mobility maze, retinal function, retinal structure and quality of life measures.

December 7, 2017

·

4 min read